Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

U.S. revenue saw a decline of 9.9% to $91.4 million, with decreases in both permanent implant and trial procedures ... to its impending acquisition by Globus Medical, an all-cash deal valued ...

U.S. revenue saw a decline of 9.9% to $91.4 million, with decreases in both permanent implant and trial procedures ... provide guidance for 2025 due to its impending acquisition by Globus Medical, an ...

Globus Medical, Inc. GMED continues to benefit from ... competitive rep recruiting from prior quarters and increased implant usage through robotic pull-through. In the fourth quarter, Globus ...

SI-BONE, Inc. reported $48 million in sales and an operating loss of $4.5 million for the quarter ending December 31, 2024. The full year 2024 revenue, which was in line with Wall Street’s ...